Panagora Asset Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Panagora Asset Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-308	Closed	-$1K	–	2551
2021 Q2	$1K	Sell	308 -16	-5%	-$51	﹤0.01%	2730
2021 Q1	$1K	Hold	324	–	–	﹤0.01%	2800
2020 Q4	$1K	Buy	+324	New	+$1.37K	﹤0.01%	2766
2020 Q3	–	Sell	-285	Closed	-$2K	–	2795
2020 Q2	$2K	Hold	285	–	–	﹤0.01%	2487
2020 Q1	$1K	Sell	285 -1	-0.3%	-$11	﹤0.01%	2464
2019 Q4	$4K	Buy	+286	New	+$2.64K	﹤0.01%	2298
2016 Q2	–	Sell	-91	Closed	-$9K	–	2365
2016 Q1	$9K	Sell	91 -220	-71%	-$24K	﹤0.01%	2220
2015 Q4	$63K	Sell	311 -76	-20%	-$13.6K	﹤0.01%	1916
2015 Q3	$56K	Buy	387 +144	+59%	+$26.4K	﹤0.01%	1968
2015 Q2	$52K	Sell	243 -7,531	-97%	-$1.85M	﹤0.01%	2134
2015 Q1	$1.8M	Buy	+7,774	New	+$1.88M	0.01%	814

Other funds holding BLCM

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIIC

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Panagora Asset Management's BLCM Position: Q3 2021 in Review

Panagora Asset Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2021, closing a stake of 308 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in BLCM in Q1 2015 and held it in 11 quarters. The position peaked at $1.8M in Q1 2015. 28 funds tracked by Wall St. Rank hold BLCM as of Q3 2021.

Panagora Asset Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 308 Bellicum Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1K.
Panagora Asset Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Panagora Asset Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.8M in Q1 2015.
28 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.